Inactive Instrument

Omnitel Inc Share Price Korea S.E.

Equities

IT Services & Consulting

End-of-day quote Korea S.E.
- - Intraday chart for Omnitel Inc
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 8.69B 6.41M 0 534M Sales 2023 26.77B 19.73M 0 1.64B Capitalization 115B 84.47M 0 7.03B
Net income 2022 -11.11B -8.19M - -682M Net income 2023 -45.41B -33.47M - -2.79B EV / Sales 2022 16.2 x
Net Debt 2022 3.46B 2.55M 0 212M Net cash position 2023 862M 635K 0 52.88M EV / Sales 2023 4.25 x
P/E ratio 2022
-11.8 x
P/E ratio 2023
-2.27 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 67.49%
More Fundamentals * Assessed data
T Scientific Co.,Ltd. announced that it has received KRW 2.99999997 billion in funding from WIZIT Co., Ltd. CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 2.99999997 billion in funding from WIZIT Co., Ltd. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion. CI
T Scientific Co.,Ltd. announced that it has received KRW 5 billion in funding from FSN Co., Ltd. CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 5 billion in funding from FSN Co., Ltd. CI
FSN Co., Ltd. announced that it has received KRW 10 billion in funding from T Scientific Co.,Ltd. CI
FSN Co., Ltd. announced that it expects to receive KRW 10 billion in funding from T Scientific Co.,Ltd. and other investors CI
T Scientific Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
T Scientific Co.,Ltd signed a contract to acquire It Nomads Co., Ltd from Kim Seongjin and others for KRW 21 billion. CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd CI
T Scientific Co.,Ltd announced that it has received KRW 16 billion in funding from Daiduck Piping Co., Ltd. CI
T Scientific Co.,Ltd(KOSDAQ:A057680) added to S&P Global BMI Index CI
T Scientific Co.,Ltd announced that it has received KRW 4.99999914 billion in funding from WIZIT Co., Ltd. CI
T Scientific Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Daiduck Piping Co., Ltd. and another investor CI
More news
Managers TitleAgeSince
Chief Executive Officer 51 31/17/31
Comptroller/Controller/Auditor 57 -
Members of the board TitleAgeSince
Director/Board Member 54 -
Chief Executive Officer 51 31/17/31
Director/Board Member 52 -
More insiders
T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW